secwatch.observer — SEC 8-K summary
======================================

Issuer:     SEELOS THERAPEUTICS, INC. (—)
CIK:        0001017491
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0001104659-23-121463
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seelos Therapeutics 1-for-30 reverse split; authorized shares cut to 16M
------------------------------------------------------------------------

- 1-for-30 reverse stock split effective Nov 28, 2023; fractional shares rounded up.
- Authorized common shares reduced from 480M to 16M.
- Reverse split intended to regain Nasdaq $1.00 minimum bid compliance.
- Trading symbol remains 'SEEL'; new CUSIP 81577F208.
- Proportionate adjustments to warrants, options, and equity plan exercise prices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1017491/000110465923121463/0001104659-23-121463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1017491/000110465923121463/tm2331470d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-121463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer